An Overview of the Medicare Part D Prescription Drug Benefit
Quick delivery, all round excellent service
A 2023 analysis published in JAMA Network Open found that only 28% of state Medicaid programs covered any GLP-1 RA for obesity as of January 2023, and Indiana was not among them [5]
relative cautions include pancreatitis history, diabetic retinopathy, and severe gastrointestinal disorders
Who Should Use Henry Meds Henry Meds is a good fit if you: Want compounded GLP-1 medications at competitive prices without insurance Prefer a fully online process with a live video provider consultation Want multiple medication formats (injectable and oral) Value bundled pricing with no separate membership or consultation fees Are comfortable with the trade-offs of compounded (non-FDA-approved) formulations Have read the trust analysis above and accept the documented risks Henry Meds is not ideal if you: Need insurance to cover your GLP-1 medication (try Found or Ro instead) Want brand-name Wegovy, Mounjaro, or Zepbound specifically Prioritize a perfect trust record and cannot tolerate the BBB F rating and active lawsuit Need structured behavioral coaching alongside medication Want transparent pharmacy disclosure upfront without having to ask Require easy self-service cancellation The platform serves a specific patient: someone who wants affordable, convenient access to compounded GLP-1 medications, is paying cash, understands the regulatory uncertainty around compounding in 2026, and is willing to be proactive about verifying pharmacy credentials and medication quality
